SCHEMBL23333325

SCHEMBL23333325

Cc1cnc2c(C)ccnc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 6/20 0.40
CCR5 P51681 6/20 0.40
CCR8 P51685 5/20 0.40
L3MBTL1 Q9Y468 1/20 0.35
NOS3 P29474 3/20 0.34
NOS2 P35228 3/20 0.34
KDM4E B2RXH2 2/20 0.34
GAA P10253 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2A6 P11509 1/20 0.33
PSMD14 O00487 2/20 0.32
COPS5 Q92905 1/20 0.32
UHRF1 Q96T88 1/20 0.32
AURKA O14965 1/20 0.32
ADRA1D P25100 2/20 0.31
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
RAB9A P51151 2/20 0.30
CBFB Q13951 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18256848 0.80 KDM4E (0.33) CCR1CCR5CCR8KDM4EGAA
SCHEMBL12847495 0.80 CCR1 (0.38) CCR1CCR5CCR8L3MBTL1NOS3
SCHEMBL18779092 0.80 ADRA2A (0.35) CCR1CCR5CCR8KDM4EGAA
SCHEMBL23332993 0.80 NOS2 (0.41) CCR1CCR5CCR8L3MBTL1NOS3
SCHEMBL18779067 0.77 LMNA (0.32) CCR1CCR5CCR8KDM4EGAA
SCHEMBL3156717 0.75 CCR1 (0.54) CCR1CCR5CCR8L3MBTL1NOS3
SCHEMBL15925264 0.73 HRH4 (0.50) CYP1A2ALDH1A1
SCHEMBL15925256 0.72 ALDH1A1 (0.43) KDM4EGAACYP1A2RAB9AALDH1A1
SCHEMBL9909767 0.71 ADORA1 (0.42) L3MBTL1CYP1A2CYP2A6ALDH1A1LMNA
SCHEMBL12847024 0.71 CCR1 (0.40) CCR1CCR5CCR8L3MBTL1NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021254493-A1 CYCLIC COMPOUND HAVING ANTI-TUMOR ACTIVITY AND USE THEREOF 上海翊石医药科技有限公司 2021-12-23 WO disclosed
EP-3148996-B1 C2-CARBOCYCLIC IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME (US) 2021-05-05 EP disclosed